Let's Build Better Cells Together
Navigate your way from concept to clinic by partnering with MaxCyte®.
We've spent over 20 years perfecting the art of cell engineering and venturing beyond today's process to innovate tomorrow's solutions. Our ExPERT™ instruments feature best-in-class electroporation technology combining high efficiency and cell viability with seamless scalability, all backed by a global team of technical and regulatory experts providing ongoing support.
We provide the spark of collaboration empowering research into treatments and cures that will transform human health. Chart your best course with MaxCyte.
Our customers are priority number one for MaxCyte
Explore the research we've supported
See how MaxCyte technology is advancing our partners' biomedical innovations
We're here throughout your journey
Because bringing a new therapeutic to market is a long and complex endeavor, we offer our expertise to support your innovations and chart a more direct course to success.
The benefits of our collaborative approach can be seen in over 35 clinical trials. Our technology has enabled studies by leaders in pharmaceutical and biotechnology research developing treatments for a variety of indications including cancer, heart disease, central nervous system disorders and rare genetic diseases.
Our Partners
Show More
Resources
MaxCyte News
Latest News
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation platform
June 25, 2024
On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
February 26, 2024
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers
January 30, 2024